Article
Identification and validation of predictive factors for progression to severe COVID-19 pneumonia by proteomics
3 Oct 2020
Abstract excerpt
Recent study showed that around 80% of coronavirus disease-19 (COVID-19) patients are moderate cases who will recover with or without conventional treatment, while the remaining 20% developed severe disease requiring intensive care. 1 Early and accurate screening of new COVID-19 patients to identify those who will develop severe disease will facilitate decision-making on appropriate treatment regimens and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
